Shinji Takeuchi

Has grant

Kanazawa University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Development of Novel Therapies Targeting Apoptosis Resistance Factors in ALK-rearranged Lung Cancer

Open Date: 2020-04-01

Close Date: 2024-03-31

Grant: Close

Development of treatment to overcome TKI resistance caused by EMT in lung cancer

Open Date: 2018-04-01

Close Date: 2021-03-31

Grant: Close

Development of therapy for overcoming resistance to mutant selective EGFR-TKI due to persistance of apoptosis

Open Date: 2017-04-01

Close Date: 2021-03-31

Grant: Close

ＢＩＭ遺伝子多型陽性癌におけるＨＤＡＣ阻害薬の耐性克服効果を最適化する薬力学的効果の指標を探索する研究

Open Date: 2014-04-01

Close Date:

Grant: Close

Development of therapy for circumvention of EGFR-TKI resistance due to BIM polymorphism in EGFR mutant lung cancer.

Open Date: 2013-04-01

Close Date: 2015-03-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Collaborators (6)

Seiji Yano

JAPAN

View details

Koji Fukuda

Kanazawa University

JAPAN

View details

Shoichiro Tange

Sapporo Medical University

JAPAN

View details

Norio Yamamoto

准教授 / Associate Professor

Kyoto University

JAPAN

View details

Hiroshi Kotani

Assistant Professor

Kanazawa University

JAPAN

View details

Atsushi Tajima

Professor

Kanazawa University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shinji Takeuchi

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer

Pembrolizumab efficacy in a tumor mutation burden‐high glioblastoma patient: A case study and implications for precision oncology

Case Report: Medullary carcinoma of the pancreas with <i>MLH1</i> promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor.

Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations

Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice.

Challenges in the treatment of <i>BRAF</i> K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib.

Case report: Navigating treatment pathways for cardiac intimal sarcoma with <i>PDGFRβ</i> N666K mutation.

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.

FIGHT-102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies.

Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1‐rearranged tumor cells

Collaborators (6)

Seiji Yano

Koji Fukuda

Shoichiro Tange

Norio Yamamoto

Hiroshi Kotani

Atsushi Tajima

Make your next move.

Shinji Takeuchi

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer

Pembrolizumab efficacy in a tumor mutation burden‐high glioblastoma patient: A case study and implications for precision oncology

Case Report: Medullary carcinoma of the pancreas with &lt;i&gt;MLH1&lt;/i&gt; promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor.

Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations

Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice.

Challenges in the treatment of <i>BRAF</i> K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib.

Case report: Navigating treatment pathways for cardiac intimal sarcoma with <i>PDGFRβ</i> N666K mutation.

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.

FIGHT-102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies.

Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1‐rearranged tumor cells

Collaborators (6)

Seiji Yano

Koji Fukuda

Shoichiro Tange

Norio Yamamoto

Hiroshi Kotani

Atsushi Tajima

Make your next move.

Case Report: Medullary carcinoma of the pancreas with <i>MLH1</i> promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor.